Warfarin-related nephropathy in patients with chronic kidney disease

Kidney International

Volumn 82, Issue 1, 2012, Pages 113-

  Woo, Keng T ^a   Lee, Grace S L ^a   Foo, Marjorie W Y ^a   Chan, Choong M ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DIPYRIDAMOLE; WARFARIN;

ACUTE KIDNEY FAILURE; ASIAN; CHRONIC KIDNEY DISEASE; DRUG INDUCED DISEASE; DRUG SAFETY; ERYTHROCYTE COUNT; GLOMERULAR BLEEDING; HERBAL MEDICINE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY HEMORRHAGE; LETTER; PRESCRIPTION; PRIORITY JOURNAL; PROTEINURIA; THROMBOTEST; URINALYSIS; WARFARIN RELATED NEPHROPATHY;

EID: 84862492560     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.91     Document Type: Letter

References (4)

1. Brodsky SV, Nadasdy T, Rovin BH et al. Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increase mortality rate. Kidney Int 2011; 80: 181-189.
2. Walker RG, Yu SH, Owen JE et al. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two year prospective trial. Clin Nephrol 1990; 34: 103-107. (Pubitemid 20295702)
3. Woo KT, Edmondson RPS, Yap HK et al. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis. Clin Nephrol 1987; 27: 56-64. (Pubitemid 17013773)
4. Woo KT, Lee GSL, Pall AA. Dipyridamole and low-dose warfarin without cyclophosphamide in the management of IgA nephropathy. Kidney Int 2000; 57: 348-349. (Pubitemid 30227789)